Citation Impact

Citing Papers

Psychophysical examination in patients with post-mastectomy pain
2000
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
Peripheral nerve damage associated with administration of taxanes in patients with cancer
2008
National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis
2014
Ovarian cancer
2014 Standout
Drug development from marine natural products
2008 Standout
Cumulative toxicities from cisplatin therapy and current cytoprotective measures
1998
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Current Management Strategies for Ovarian Cancer
2007
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
2014 Standout
Extracorporeal photopheresis and liver transplantation: Our experience and preliminary data
2017
Primary surgery for ovarian cancer
2006
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Persistent postsurgical pain: risk factors and prevention
2006 Standout
Extracorporeal photopheresis for the treatment of autoimmune diseases
2015
Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series
2012
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Clinical and electrophysiological features of peripheral neuropathy induced by administration of cisplatin plus paclitaxel-based chemotherapy
2007
Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly schedule
2002
A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cells
2016 StandoutNobel
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Cisplatin: The first metal based anticancer drug
2019 Standout
Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review
2008
Photopheresis: Advances and Use in Systemic Sclerosis
2017
Immunological Functions of the Omentum
2017 Standout
Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
2010
Efficacy of gabapentin in the management of chemotherapy‐induced peripheral neuropathy
2007
The omentum and omentectomy in epithelial ovarian cancer: A reappraisal
2013
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Efficacy of lamotrigine in the management of chemotherapy‐induced peripheral neuropathy
2008
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The omentum.
2000
The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer
2005
Current Management Strategies for Ovarian Cancer
2007
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial
2003
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout

Works of S Rota being referenced

The accuracy of staging: An important prognostic determinator in stage I ovarian carcinoma
1998
Extracorporeal photochemotherapy: a safety and tolerability pilot study with preliminary efficacy results in refractory relapsing-remitting multiple sclerosis
2006
Conservative surgery for Stage I ovarian carcinoma in women of childbearing age
1997
Neurotoxicity and ototoxicity of cisplatin plus paclitaxel in comparison to cisplatin plus cyclophosphamide in patients with epithelial ovarian cancer.
1997
Multimodality therapy of early-stage (FIGO I-II) ovarian cancer: review of surgical management and postoperative adjuvant treatment
1996
Behavior of Borderline Tumors With Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective Study
2001
Rankless by CCL
2026